Cayuga Nation announces cannabis growing plans | Business | auburnpub.com – The Citizen

With cannabis sales already underway at its stores in Cayuga and Seneca counties, the Cayuga Nation plans to begin growing the plant commercially by the end of the year.

In a news release Monday, the nation announced that it will grow cannabis at an indoor, 15,000-square-foot building on its Gakwiyo (Cayuga for „good food”) Garden property in Seneca Falls.

Architectural firm Bergmann, of Rochester, will oversee development of the facility, and Jake Brewer will oversee development of the nation’s cannabis businesses. Brewer previously served as head grower for a cannabis company in Colorado, the nation said. It is now finalizing blueprints for the facility with Bergmann, and construction will begin this year.

The facility will „likely” open by the end of the year, the nation said.

“As a sovereign nation, the Cayuga Nation can grow and sell cannabis within its reservation’s boundaries,” the nation said in a statement.

„Similar to the Nation’s other economic development initiatives, cannabis presents an opportunity to generate economic growth for the Nation and its members, while creating jobs for the community. Developing our cannabis business is the next step in expanding and diversifying the Cayuga Nation’s economic opportunities and providing long-lasting benefits to the community. Our vision for the future of the Cayuga Nation remains focused on bettering the lives of our members, our community, and our neighbors. As we venture forward in our economic development, we remain committed to working closely with local governments to ensure the health and safety of our community.”

People are also reading…

The nation received approval from the USDA to grow and sell hemp (cannabis with .3% THC content or less) on its land in 2020. Last week, Gov. Kathy Hochul signed legislation allowing the state’s hemp farmers to apply for conditional licenses to grow cannabis in order to „jumpstart the safe, equitable and inclusive new industry we are building,” she said in a press release.

The nation began selling untaxed cannabis at the Union Springs and Seneca Falls locations of its Lakeside Trading business last fall. Though the state has yet to begin licensing retail dispensaries — a process that possibly won’t begin until 2023 — the nation is already able to sell cannabis due to tribal sovereignty, the state Office of Cannabis Management has affirmed.

The state’s Marijuana Regulation and Taxation Act, passed in March 2021, prohibits holders of dispensary licenses from also holding cultivation, processing or distribution licenses. The rule is one of many in the law meant to prevent vertical integration in the state’s new cannabis industry. However, the nation said „as a sovereign entity (it) is not limited or bound by local prohibitions.”

Lake Life Editor David Wilcox can be reached at (315) 282-2245 or david.wilcox@lee.net. Follow him on Twitter @drwilcox.

Cayuga Nation announces cannabis growing plans | Business | auburnpub.com – Auburn Citizen

With cannabis sales already underway at its stores in Cayuga and Seneca counties, the Cayuga Nation plans to begin growing the plant commercially by the end of the year.

In a news release Monday, the nation announced that it will grow cannabis at an indoor, 15,000-square-foot building on its Gakwiyo (Cayuga for „good food”) Garden property in Seneca Falls.

Architectural firm Bergmann, of Rochester, will oversee development of the facility, and Jake Brewer will oversee development of the nation’s cannabis businesses. Brewer previously served as head grower for a cannabis company in Colorado, the nation said. It is now finalizing blueprints for the facility with Bergmann, and construction will begin this year.

The facility will „likely” open by the end of the year, the nation said.

“As a sovereign nation, the Cayuga Nation can grow and sell cannabis within its reservation’s boundaries,” the nation said in a statement.

„Similar to the Nation’s other economic development initiatives, cannabis presents an opportunity to generate economic growth for the Nation and its members, while creating jobs for the community. Developing our cannabis business is the next step in expanding and diversifying the Cayuga Nation’s economic opportunities and providing long-lasting benefits to the community. Our vision for the future of the Cayuga Nation remains focused on bettering the lives of our members, our community, and our neighbors. As we venture forward in our economic development, we remain committed to working closely with local governments to ensure the health and safety of our community.”

People are also reading…

The nation received approval from the USDA to grow and sell hemp (cannabis with .3% THC content or less) on its land in 2020. Last week, Gov. Kathy Hochul signed legislation allowing the state’s hemp farmers to apply for conditional licenses to grow cannabis in order to „jumpstart the safe, equitable and inclusive new industry we are building,” she said in a press release.

The nation began selling untaxed cannabis at the Union Springs and Seneca Falls locations of its Lakeside Trading business last fall. Though the state has yet to begin licensing retail dispensaries — a process that possibly won’t begin until 2023 — the nation is already able to sell cannabis due to tribal sovereignty, the state Office of Cannabis Management has affirmed.

The state’s Marijuana Regulation and Taxation Act, passed in March 2021, prohibits holders of dispensary licenses from also holding cultivation, processing or distribution licenses. The rule is one of many in the law meant to prevent vertical integration in the state’s new cannabis industry. However, the nation said „as a sovereign entity (it) is not limited or bound by local prohibitions.”

Lake Life Editor David Wilcox can be reached at (315) 282-2245 or david.wilcox@lee.net. Follow him on Twitter @drwilcox.

Shopify Reportedly Cracking Down On Hemp Derived THC Sales – HempGazette

Canadian multinational e-commerce platform Shopify is reportedly removing hemp derived high-THC products from sellers’ stores.

CBDTesters’ Alexandra Hicks states an email from the ecommerce giant has been sent to various merchants identified as selling delta-8 tetrahydrocannabinol (THC) products containing more than 0.3% THC.

Shopify has reportedly stated in the emails its policies do not currently permit merchants to offer for sale products containing more than 0.3% THC; regardless of compound type.

According to Shopify’s hemp page, sellers providing products to the USA must provide an attestation stating among other things:

“Your products contain no more than 0.3% THC, regardless of compound type, such as delta-8, delta-9, and delta-10.”

And for international sales:

“The products you sell can’t contain more than 0.2% of THC, regardless of the compound type, such as delta-8, delta-9, and delta-10.”

Hemp derived THC in its various forms have created a storm of controversy over the last year or so – first with delta-8, which can be created by manipulating CBD (cannabidiol), then delta-10 and more recently the concentration of delta-9 from hemp for use in various products.

The 2018 Farm Bill defined hemp as cannabis within a threshold of 0.3% delta-9 THC on a dry weight basis. This is a very low level with no recreational or “adult use” value. However, the wording has created a perceived loophole for the creation of other “deltas” or concentration of the low levels of THC present in hemp.

Last week, the US hemp industry’s national advocacy organization again condemned the marketing of intoxicating products under the guise of hemp, stating health concerns and a violation of the intent of Congress with regard to the 2018 Farm Bill.

The situation has certainly demonstrated that words matter; particularly in relation to rules and regulations as there will always be attempts to circumvent them.

Back in 2019, Shopify began allowing U.S.-based retailers to sell select hemp or hemp-derived CBD products via its commerce platform, with conditions. It began permitting Canadian merchants to sell CBD products via its platform in 2018.

Anesthesia Vaporizers Market is Booming Worldwide with Dragerwerk, GE Healthcare – corporate ethos – corporate ethos

Anesthesia Vaporizers Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing top players and the upcoming competitors. Business strategies of the key players and the new entering market industries are studied in detail. Well explained SWOT analysis, revenue share and contact information are shared in this report analysis. It also provides market information in terms of development and its capacities.

Get Sample Copy of this report with latest Industry Trend and COVID-19 Impact @: https://www.a2zmarketresearch.com/sample-request/60477

Some of the Top companies Influencing in this Market includes:

Dragerwerk, GE Healthcare, Penlon, Meditec, Oricare, Spacelabs Healthcare, OES Medical, Beijing Siriusmed Medical Device, Beijing Vanbonmed.

Various factors are responsible for the market’s growth trajectory, which are studied at length in the report. In addition, the report lists down the restraints that are posing threat to the global Anesthesia Vaporizers market. This report is a consolidation of primary and secondary research, which provides market size, share, dynamics, and forecast for various segments and sub-segments considering the macro and micro environmental factors. It also gauges the bargaining power of suppliers and buyers, threat from new entrants and product substitute, and the degree of competition prevailing in the market.

Global Anesthesia Vaporizers Market Segmentation:

Market Segmentation: By Type

Plenum Vaporizers, Drawover Vaporizers

Market Segmentation: By Application

Hospitals, Clinics, ASCs

Global Anesthesia Vaporizers Market research report offers:

  • Market definition of the global Anesthesia Vaporizers market along with the analysis of different influencing factors like drivers, restraints, and opportunities.
  • Extensive research on the competitive landscape of global Anesthesia Vaporizers
  • Identification and analysis of micro and macro factors that are and will effect on the growth of the market.
  • A comprehensive list of key market players operating in the global Anesthesia Vaporizers market.
  • Analysis of the different market segments such as type, size, applications, and end-users.
  • It offers a descriptive analysis of demand-supply chaining in the global Anesthesia Vaporizers market.
  • Statistical analysis of some significant economics facts
  • Figures, charts, graphs, pictures to describe the market clearly.

Get Up to 30% Discount on the first purchase of this report @: https://www.a2zmarketresearch.com/discount/60477

Regions Covered in the Global Anesthesia Vaporizers Market Report 2020:
The Middle East and Africa (GCC Countries and Egypt)
North America (the United States, Mexico, and Canada)
South America (Brazil etc.)
Europe (Turkey, Germany, Russia UK, Italy, France, etc.)
Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

The cost analysis of the Global Anesthesia Vaporizers Market has been performed while keeping in view manufacturing expenses, labor cost, and raw materials and their market concentration rate, suppliers, and price trend. Other factors such as Supply chain, downstream buyers, and sourcing strategy have been assessed to provide a complete and in-depth view of the market. Buyers of the report will also be exposed to a study on market positioning with factors such as target client, brand strategy, and price strategy taken into consideration.

Key questions answered in the report include:

  • What will be the market size and the growth rate by the end of the forecast period?
  • What are the key Anesthesia Vaporizers Market trends impacting the growth of the market?
  • What are the potential growth opportunities and threats faced by the leading competitors in the market?
  • What are the key outcomes of Porter’s five forces analysis and the SWOT analysis of the key players functioning in the global Anesthesia Vaporizers Market?
  • This report gives all the information regarding industry Overview, analysis and revenue of this market.
  • What are the market opportunities and threats faced by the vendors in the global Anesthesia Vaporizers market?

Table of Contents

Global Anesthesia Vaporizers Market Research Report 2021 – 2029

Chapter 1 Anesthesia Vaporizers Market Overview

Chapter 2 Global Economic Impact on Industry

Chapter 3 Global Market Competition by Manufacturers

Chapter 4 Global Production, Revenue (Value) by Region

Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6 Global Production, Revenue (Value), Price Trend by Type

Chapter 7 Global Market Analysis by Application

Chapter 8 Manufacturing Cost Analysis

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

Chapter 11 Market Effect Factors Analysis

Chapter 12 Global Anesthesia Vaporizers Market Forecast

Buy Exclusive Report: https://www.a2zmarketresearch.com/checkout

If you have any special requirements, please let us know and we will offer you the report as you want.

About A2Z Market Research:

The A2Z Market Research library provides syndication reports from market researchers around the world. Ready-to-buy syndication Market research studies will help you find the most relevant business intelligence.

Our Research Analyst Provides business insights and market research reports for large and small businesses.

The company helps clients build business policies and grow in that market area. A2Z Market Research is not only interested in industry reports dealing with telecommunications, healthcare, pharmaceuticals, financial services, energy, technology, real estate, logistics, F & B, media, etc. but also your company data, country profiles, trends, information and analysis on the sector of your interest.

Contact Us:

Roger Smith

1887 WHITNEY MESA DR HENDERSON, NV 89014

sales@a2zmarketresearch.com

+1 775 237 4147

Lawmaker’s CBD enterprise forced to pay back $144000 to investors after state investigation – Chicago Sun-Times

State Sen. Patricia Van Pelt’s embattled CBD business has paid back more than $144,000 to investors as part of a settlement agreement stemming from an investigation by the Illinois secretary of state’s office, the Chicago Sun-Times has learned.

WaKanna For Life LLC, the Chicago Democrat’s Douglas-based multilevel marketing firm, is touted as a “movement” that has helped thousands of African Americans sell hemp-based CBD, or cannabidiol, a legal and nonpsychoactive compound also found in cannabis that’s used to treat a range of conditions. The company’s “founders” — Van Pelt, CEO Melissa Boston, Dr. Rita McGuire and Phyllis Nash — are all Black women.

Van Pelt began hosting cannabis investment workshops as Illinois’ pot legalization push gained steam in early 2019.

“I’m riding the wave with the rich,” she says in a promotional video that showed her talking to a crowd about becoming “marijuana millionaires.”

Within months of its launch that year, WaKanna For Life started using a network of distributors to sell products containing CBD. Around the same time, Boston said the company planned to seek licenses to grow and sell weed.

But WaKanna For Life and its subsidiaries have since faced multiple consumer complaints and investigations, the Sun-Times has learned.

Meanwhile, the vast majority of those who pay for training to set up online “dispensaries” to sell products like creams and lotions with CBD make an average of only a couple hundred bucks, the Sun-Times found.

After WCIA in Springfield reported on Van Pelt’s pot-related endeavors in May 2019, she was swiftly removed as a co-sponsor of the legalization measure and a conflict of interest ban was later added. In addition, the secretary of state’s office opened an investigation.

That probe has apparently centered on WaKanna Investors LLC, an “investment vehicle” that holds a 49% interest in WaKanna For Life, according to documents obtained through a Freedom of Information Act request. Those two entities — along with WaKanna LLC, which controls the majority ownership of WaKanna For Life — make up a web of interconnected companies looking to cash in on the highly competitive and loosely regulated CBD trade.

In a statement of economic interests filed last year, Van Pelt is listed as the president of both WaKanna and WaKanna For Life. Her name only appears in WaKanna’s incorporation records as a manager, according to the agency.

Records show that Boston admitted WaKanna Investors flouted state and federal regulations in 2019 by raising $305,000 from 71 investors — more than double the number of permitted backers for a company seeking an exemption to avoid registering its securities. In order to retain that exemption, the company specifically had to refund investments made by out-of-state residents.

WaKanna Investors had sought to unload up to $1 million worth of shares, or LLC units, according to “report of sale” documents that were initially misfiled and weren’t submitted within the allotted timeframe.

In an affidavit last May explaining WaKanna Investors’ efforts to come into compliance, Boston said 30 investors paying on an installment basis first had their plans canceled. The company then offered to buy back shares from 40 other investors with 10% interest, a move Boston described as “a mandated corrective measure.”

Roughly $62,000 was returned to those who were paying in installments, and another $82,250 went to five other investors who accepted the so-called rescission offer, according to David Finnigan of the secretary of state’s office. The offer specifically warned that WaKanna Investors was a shaky bet with just a year of operating history, “ongoing further capital needs” and other risk factors.

State Sen. Patricia Van Pelt speaks during a press conference about the opening of the new COVID-19 mass vaccination site on the parking lot of the United Center in the Near West Side neighborhood, Tuesday morning, March 9, 2021. | Pat Nabong/Sun-Times
State Sen. Patricia Van Pelt speaks during a news conference about the opening of the new COVID-19 mass vaccination site on the parking lot of the United Center in the Near West Side neighborhood on March 9, 2021.
Pat Nabong/Sun-Times file

In interviews with the Sun-Times, Van Pelt and Boston, who previously worked for the Danish shipping giant Maersk, both blamed the issues on a lawyer’s bad advice.

“The legal concern was mainly that it was offered to non-state residents, when it should have only been offered to state residents,” Boston said of the LLC unit sale, noting that only out-of-staters accepted the rescission deal.

“There was never any intent, nor attempt to evade the law, quite the opposite,” she added. “WaKanna sought and followed the advice of an attorney.”

Secretary of State Jesse White, Van Pelt’s longtime political ally, has recused himself from his agency’s investigation of the WaKanna entities, Finnigan said. White was previously recruited by Van Pelt to invest in 5Linx, another multilevel marketing firm that offered health insurance, nutritional supplements and business, utility and telecommunications services.

The three co-founders of 5Linx were later convicted of federal charges after admitting to defrauding investors out of more than $2 million. Van Pelt, after rising to the position of senior vice president, wasn’t charged in connection to the fraud scheme.

The payoffs to investors left WaKanna Investors with 35 outside backers — the most allowed by state and federal regulations — but the investigation remained open for months. Finnigan also confirmed his team has cooperated with other investigations, though he declined to name the other agencies probing the WaKanna entities.

In an interview, Van Pelt acknowledged she was questioned by the state’s office of the legislative inspector general about her cannabis investment coaching. She insisted the inquiry had run its course, though a spokesman for the legislative inspector general’s office wouldn’t comment even to confirm or deny an investigation.

‘I didn’t feel I was made whole’

WaKanna For Life has also been the subject of a series of consumer complaints received by the Federal Trade Commission and the Illinois attorney general’s office, according to records obtained by the Sun-Times.

The FTC has fielded at least five complaints over the past two years, including allegations the company was sending unsolicited messages, requesting personal information and “charging people to attend seminars for training [on] how to be their own boss and start their own business.”

Both the FTC and the attorney general’s office logged nearly duplicative complaints last December that raise questions about WaKanna For Life’s business practices and appear to relate to the company’s ill-fated effort to sell off shares.

Karen Mason, a WaKanna For Life distributor, complained that over seven months in 2019 she spent nearly $1,800 on two “dispensary” packages containing CBD products, business tools, classes and support services — purchases that were premised on Boston’s assurances that she would also receive shares of stock and a chance to receive a portion of the company’s revenue. But Mason never received any official documentation, according to the complaints.

In addition, Mason claimed she hadn’t received the “appropriate commissions” on more than $5,000 in gross sales. Mason asked for documentation of any “shares of stock” and commissions or a refund of $6,797 to cover her sales and purchases, according to the complaint filed with the attorney general’s office.

WaKanna For Life’s attorney, Boyd Jentzsch, claimed the company responded to the complaints by providing “point-by-point documentation” that showed the allegations were false. Still, Jentzsch said the company offered a full refund if the products in question were returned in good condition.

That never happened, according to Jentzsch, who claimed Mason even continued ordering products from the company. He further claimed the matters “are now considered closed,” though Mason disagreed.

While she acknowledged that Boston reached out and offered to buy back products, Mason told the Sun-Times she never received records of the shares she was promised or a refund of what she believed was investment money.

“I didn’t feel I was made whole. … The resolution that Ms. Boston gave me was not a resolution. I still feel my complaint is unresolved,” said Mason, who nevertheless lauded some of WaKanna’s products but said she stopped purchasing them shortly after filing the complaints.

A spokesman for the FTC declined to discuss WaKanna For Life. A spokeswoman for the attorney general’s office said its complaint was sent to the Illinois Department of Financial and Professional Regulation, though an agency spokesman didn’t respond to requests for comment.

Mason noted she was also referred to a special agent in the secretary of state’s office’s securities division, who she remained in contact with for months last year.

A South Sider with a background performing audits and doing compliance work, Mason said she also noticed glaring gaps in WaKanna For Life’s operations when she was hired to conduct a fixed asset review at the company’s headquarters at 411 E. 35th St. For example, she said there was no documentation of the building’s assets and no accounting of the inventory held there.

She also raised concerns over the company’s convoluted seven-tiered compensation plan, noting that a friend wasn’t elevated to a higher — and more lucrative — sales level after hitting the stated goal of reaching $10,000 in revenue in a month. In her complaints, Mason warned that inconsistencies in the plan “can be viewed as presenting misleading and inaccurate information” and could pose “a reputational and financial risk to WaKanna.”

“They have done some things that would be viewed as suspect,” she told the Sun-Times.

WaKanna’s website advertises the “highest quality CBD products.”
wakanna.com

WaKanna For Life requires distributors to pay for training after a free trial period and to purchase costly products to sell through personalized online “dispensaries.” On its websites, the company has touted its “lucrative compensation plan,” noting that its leaders “have shaped multi-billion dollar companies and have helped empower over 5,000 minorities to join the Cannabis/CBD space.”

But according to WaKanna For Life’s own “income disclosure statement,” which includes figures from May 2019 through the end of last year, 90% of the company’s total affiliates made an average of $200 or less annually.

“Note that it takes hard work to make substantial income in this business and some Independent Sales Representative’s [sic] make no money at all,” WaKanna’s websites warn.

Van Pelt reiterated that statement, noting that distributors “don’t make money from not working.” But she also said she believes that some people join the company simply to purchase discounted products for their own use.

After reviewing unaudited financial statements presented in an online meeting in August 2020, Mason specifically accused Van Pelt of not being straight with affiliates when she claimed WaKanna For Life had grossed more than $3 million.

“That was TOTALLY incorrect!!” Mason wrote in an email to a WaKanna For Life consultant and Nathalie Thompson, the company’s vice president at the time.

The rescission offer sent to investors provides only a limited window into the WaKanna entities’ finances. By July 2020, WaKanna For Life reported paying out over $654,000 in commissions from $2.2 million in total sales. But that didn’t include “the tens of thousands of dollars” that went to the company’s “corporate staff,” the offer stated.

At the time, WaKanna For Life’s backers owned just 4% of the company. The board of managers — which included Van Pelt, Boston, McGuire, Nash and Thompson — controlled the rest.

Van Pelt said the company has now generated more than $7 million in sales.

Some of the products for sale at wakanna.com.

LNG Mobile Vaporizers Market Outlook: Post Covid-19 Scenario by 2029 | Kobe Steel, Teyco Comercial SL – corporate ethos – corporate ethos

LNG Mobile Vaporizers Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing top players and the upcoming competitors. Business strategies of the key players and the new entering market industries are studied in detail. Well explained SWOT analysis, revenue share and contact information are shared in this report analysis. It also provides market information in terms of development and its capacities.

Get Sample Copy of this report with latest Industry Trend and COVID-19 Impact @: https://www.a2zmarketresearch.com/sample-request/565490

Some of the Top companies Influencing in this Market includes:

Kobe Steel, Teyco Comercial SL, CEXI, Chart Industries, Inc, Cryeng Group, Cryonorm BV, Linde, Nikkiso Co., Ltd (Cryoquip), Incryo Systems, Kwangsan Co., Ltd, Clean Energy Fuels.

Various factors are responsible for the market’s growth trajectory, which are studied at length in the report. In addition, the report lists down the restraints that are posing threat to the global LNG Mobile Vaporizers market. This report is a consolidation of primary and secondary research, which provides market size, share, dynamics, and forecast for various segments and sub-segments considering the macro and micro environmental factors. It also gauges the bargaining power of suppliers and buyers, threat from new entrants and product substitute, and the degree of competition prevailing in the market.

Global LNG Mobile Vaporizers Market Segmentation:

Market Segmentation: By Type

40-200 Gal/hr
200-500 Gal/hr
500-1000 Gal/hr
More than 1000 Gal/hr

Market Segmentation: By Application

Industrial
Commercial
Agriculture
Others

Global LNG Mobile Vaporizers Market research report offers:

  • Market definition of the global LNG Mobile Vaporizers market along with the analysis of different influencing factors like drivers, restraints, and opportunities.
  • Extensive research on the competitive landscape of global LNG Mobile Vaporizers
  • Identification and analysis of micro and macro factors that are and will effect on the growth of the market.
  • A comprehensive list of key market players operating in the global LNG Mobile Vaporizers market.
  • Analysis of the different market segments such as type, size, applications, and end-users.
  • It offers a descriptive analysis of demand-supply chaining in the global LNG Mobile Vaporizers market.
  • Statistical analysis of some significant economics facts
  • Figures, charts, graphs, pictures to describe the market clearly.

Get Up to 30% Discount on the first purchase of this report @: https://www.a2zmarketresearch.com/discount/565490

The cost analysis of the Global LNG Mobile Vaporizers Market has been performed while keeping in view manufacturing expenses, labor cost, and raw materials and their market concentration rate, suppliers, and price trend. Other factors such as Supply chain, downstream buyers, and sourcing strategy have been assessed to provide a complete and in-depth view of the market. Buyers of the report will also be exposed to a study on market positioning with factors such as target client, brand strategy, and price strategy taken into consideration.

Key questions answered in the report include:

  • What will be the market size and the growth rate by the end of the forecast period?
  • What are the key LNG Mobile Vaporizers Market trends impacting the growth of the market?
  • What are the potential growth opportunities and threats faced by the leading competitors in the market?
  • What are the key outcomes of Porter’s five forces analysis and the SWOT analysis of the key players functioning in the global LNG Mobile Vaporizers Market?
  • This report gives all the information regarding industry Overview, analysis and revenue of this market.
  • What are the market opportunities and threats faced by the vendors in the global LNG Mobile Vaporizers market?

Table of Contents

Global LNG Mobile Vaporizers Market Research Report 2021 – 2028

Chapter 1 LNG Mobile Vaporizers Market Overview

Chapter 2 Global Economic Impact on Industry

Chapter 3 Global Market Competition by Manufacturers

Chapter 4 Global Production, Revenue (Value) by Region

Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6 Global Production, Revenue (Value), Price Trend by Type

Chapter 7 Global Market Analysis by Application

Chapter 8 Manufacturing Cost Analysis

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

Chapter 11 Market Effect Factors Analysis

Chapter 12 Global LNG Mobile Vaporizers Market Forecast

Buy Exclusive Report: https://www.a2zmarketresearch.com/checkout

If you have any special requirements, please let us know and we will offer you the report as you want.

About A2Z Market Research:

The A2Z Market Research library provides syndication reports from market researchers around the world. Ready-to-buy syndication Market research studies will help you find the most relevant business intelligence.

Our Research Analyst Provides business insights and market research reports for large and small businesses.

The company helps clients build business policies and grow in that market area. A2Z Market Research is not only interested in industry reports dealing with telecommunications, healthcare, pharmaceuticals, financial services, energy, technology, real estate, logistics, F & B, media, etc. but also your company data, country profiles, trends, information and analysis on the sector of your interest.

Contact Us:

Roger Smith

1887 WHITNEY MESA DR HENDERSON, NV 89014

sales@a2zmarketresearch.com

+1 775 237 4147

Global Pet CBD(cannabidiol) Market 2021 to 2027 – Industry Scope and Growth Strategies by Key Players, Type, Application – corporate ethos – corporate ethos

MRInsights.biz has released a new report named Global Pet CBD(cannabidiol) Market that includes regional and global market statistics and forecasts profits between 2021 and 2027. This market is thoroughly examined in the report. The market definition, classifications, applications, engagements, and worldwide Pet CBD(cannabidiol) industry trends are all covered in this study.

Critical topics such as drivers and restraints, opportunities, production, market players, and competition have all been thoroughly studied in the report. It also includes separate chapters on regional studies to give an overview of markets with future promise, as well as annual growth projections for the survey period of 2021 to 2027.

DOWNLOAD FREE SAMPLE REPORT: https://www.mrinsights.biz/report-detail/269706/request-sample

The major findings of the survey, such as the top reasons for organisations to increase supply chain visibility in the next years, are detailed in the report’s next chapter. It focuses on a few critical aspects of current compensation in the industry.

The study includes information on market segments such as

  • Pets Gastrointestinal Diseases
  • Pet Sleep Disorder
  • Pet Anxiety

The report highlights product types which are as follows:

  • CBD Capsule
  • CBD Oil
  • CBD Jelly
  • Other

The following firms compete in the global market:

  • Canna-Pet
  • Choom Holdings
  • Receptra Naturals
  • Curaleaf
  • Trulieve Cannabis
  • Pure Spectrum
  • Cannabis Strategies Acquisition
  • Pet Releaf
  • Diamond CBD
  • PotNetwork Holdings
  • Kat’s Naturals
  • Bluebird Botanicals

The following sites were explored as part of the market split by topographical areas:

  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

ACCESS FULL REPORT: https://www.mrinsights.biz/report/global-pet-cbdcannabidiol-market-growth-2021-2026-269706.html

Reasons to get the following report:

  • Gain a complete understanding of the global marketplace by utilising comprehensive brand solutions, market share statistics, and successful market placement methods.
  • Recognize the major industries as well as the market environment.
  • Using a thorough value and volume analysis, identify potential classes.
  • Current market trends, growing application solutions, and market landscapes that firms in the Pet CBD(cannabidiol) industry may find relevant.

Customization of the Report:

This report can be customized to meet the client’s requirements. Please connect with our sales team (sales@mrinsights.biz), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

Contact Us
Mark Stone
Head of Business Development
Phone: +1-201-465-4211
Email: sales@mrinsights.biz

South Dakota House Panel Rejects Senate-Passed Marijuana Legalization Bill While Gutting Medical Cannabis Protections – Marijuana Moment

Nearly three in four New Hampshire voters support legalizing marijuana, according to a new poll. And bipartisan majorities also say they’re in favor of conducting cannabis sales through a state-run model as would be the case under a bill that recently passed the House of Representatives.

The Granite State Poll, published by the University of New Hampshire (UNH) on Friday, found that 74 percent of residents in the state feel that prohibition should end. In a separate question, sixty-eight percent said they support a bill that passed the House this month to have the state Liquor Commission exclusively conduct sales—a proposal that has raised some concerns among advocates and stakeholders.

Seventy-nine percent of Democrats, 68 percent of independents and 56 percent of Republicans said they back the unique reform approach.

Via UNH.

Meanwhile, support for legalization overall has grown demonstrably in the state over the past decade, increasing by 25 percentage points since UNH started polling residents on the issue in 2013.

Via UNH.

Just 15 percent of Granite Staters now oppose legalizing cannabis.

But while bipartisan majorities said they favor the state-run legalization proposal, it should be noted that respondents were not given an alternative regulatory model in the new poll. And when asked about legalization through a traditional, private retail model last year, 78 percent said they favor that approach.

What both surveys show, however, is that New Hampshire residents are ready to let adults legally purchase cannabis in one way or another. The latest poll found majority support for basic reform across all demographics, including age, gender and education level.

“This poll confirms, once again, that cannabis legalization is very popular with New Hampshire residents,” Matt Simon, director of public and government relations for Prime Alternative Treatment Centers of NH, told Marijuana Moment. “It also tells us something new: the liquor monopoly model is substantially (10 percent) less popular than the idea of allowing sales by licensed retail outlets. It will be interesting to see how policymakers choose to interpret these numbers.”

The new poll involved interviews with 1,081 New Hampshire residents from February 18-22. The margin of error was +/-3.0 percentage points.

The state-centered legislation from Rep. Daryl Abbas (R) cleared the chamber in a 235-119 vote this month, despite facing resistance from people on both sides of the broader cannabis debate. The action comes about a month after the House passed a separate, non-commercial legalization bill that’s also generated criticism.

Under the proposal, which must still go before the House Finance Committee because of its fiscal components and then receive another floor vote before advancing to the Senate, adults 21 and older would be able to purchase cannabis from state-run dispensaries operated by the New Hampshire Liquor Commission. The could possess up to four ounces, but home cultivation would continue to be criminalized—one of the chief complaints from activists.

State regulators would have until October 1 to adopt rules for “the registration and regulation of cannabis establishments and cannabis cultivation facilities.” They would then have another two months to create regulations on issues like advertising, labeling, civil fines, security and THC limits.

Some advocates had hoped that the legislation would be defeated so that lawmakers could consider alternative reform proposals to create a legal marijuana market that more closely aligns with those established in other states.


Marijuana Moment is already tracking more than 1,000 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.


Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.

In general, many advocates have usually welcomed whatever reforms they can achieve in the fight to end prohibition. But in New Hampshire, they’ve grown particularly impatient with the GOP-controlled legislature, especially as it advances contentious legalization options while snubbing their preferred vehicles.

The non-commercial legalization bill that passed the House last month is another example of legislation that’s fallen short of expectations. It would allow adults 21 and older to possess and give away up to three-fourths of an ounce of marijuana and grow up to six plants, but it wouldn’t permit cannabis commerce.

The bill is virtually identical to an earlier version that also passed the House under Democratic control in 2020. The previous bill died in Senate committee.

What made last month’s House vote to pass the home grow bill from Rep. Carol McGuire (R) all the more frustrating for activists was the fact that it advanced one day after the chamber narrowly rejected a separate, broader legalization proposal that would have regulated commercial production and sales.

Meanwhile, three lawmakers—Reps. Joshua Adjutant (D), Renny Cushing (D) and Andrew Prout (R)—each filed separate bills to put marijuana legalization on the state’s 2022 ballot.

It would take a supermajority 60 percent vote in both chambers to advance any of the proposed constitutional amendments. But while that may be a tall task in the GOP-controlled legislature, if they’re successful, it would enable lawmakers to avoid a likely veto on statutory reform legislation from anti-legalization Gov. Chris Sununu (R).

Should legislators approve placing a constitutional amendment to legalize cannabis on the ballot, 67 percent of voters would then have to vote in favor for it to be enacted. Recent polling indicates that residents are ready for the reform, with three in four New Hampshirites favoring legalization.

While the governor remains opposed to adult-use legalization, advocates are encouraged that he signed a bill in August adding opioid use disorder as a qualifying condition for the state’s medical cannabis program and also allows out-of-state patients to access dispensaries.

In 2017, Sununu signed a bill decriminalizing marijuana possession in the Granite State, though he continues to oppose adding a legal commercial cannabis sales component.

In 2019, lawmakers sent a medical cannabis homegrow bill to Sununu’s desk, but he vetoed it.

Meanwhile, other nearby northeast states such as Maine and Vermont have already legalized recreational cannabis.

Utah Psychedelics And Mental Health Bill Heads To Governor’s Desk After Senate Approval

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Tech helps banks navigate cannabis’ regulatory potholes – American Banker

Cannabis businesses are an underserved and potentially lucrative niche for banks. But banking pot-related companies comes with regulatory risks and legal gray areas that keep many financial institutions away.

“If you can do it properly, there is revenue to be made in this space because so few banks want to enter into it,” said Danny Schneider, the Bank Secrecy Act officer at Lead Bank in Kansas City, Missouri.

Lead Bank is one of several U.S. banks that are going ahead with pot banking, in spite of the regulatory risks, with help from tech companies that handle much of the compliance and monitoring work. For instance, by partnering with fintechs such as RiskScout and Dama Financial that perform onboarding and due diligence for cannabis businesses, banks already engaging with cannabis companies can scale that part of their business in a safer way. Such partnerships could also help banks that would like to get into cannabis banking but are wary of the risks.

A number of states have legalized some uses of cannabis, but non-hemp cannabis is still a controlled substance at the federal level. (Non-hemp cannabis or marijuana has a higher level of tetrahydrocannabinol or THC, the component of cannabis that gets users high.) Regulatory guidance on anti-money-laundering reporting gives banks some idea of how to comply with federal law regarding cannabis-business customers, such as by regularly filing cannabis-specific suspicious activity reports, or SARS.

So far, no federal statute authorizes cannabis banking. Further, Rep. Ed Perlmutter of Colorado, the author and sponsor of the Secure and Fair Enforcement (SAFE) Banking Act, will not seek reelection in 2022. The SAFE Banking Act, which would prohibit federal banking regulators from penalizing depository institutions for providing banking services to cannabis businesses in states where marijuana is legal, has largely been abandoned in favor of broader legislation to legalize marijuana.

“There is a very high resource requirement to bank the cannabis industry and we would not be able to do it to this level without partnering with a fintech,” said Danny Schneider, the BSA officer at Lead Bank in Kansas City, Missouri.

Adobe Stock

“There are the usual know-your-customer obligations, but with cannabis businesses there is an additional layer of burden in terms of assessing their compliance and maintaining and monitoring their compliance with applicable state law,” said Cliff Stanford, a partner at Alston & Bird. “Some banks say it’s not worth it. Others say there is a lot of money there, and we have at least some degree of clarity about our compliance requirements under federal law.”

There is room for regtech or fintech providers to help banks reduce the compliance burden, Stanford said.

„If there’s something they can rely upon that makes it more efficient, that could move the needle,” he said.

After banking hemp companies for two years, such as hemp testing service Delta 9 Analytical, West Town Bank & Trust, a subsidiary of Integrated Financial Holdings in Raleigh, North Carolina, expanded to banking businesses involved with other forms of cannabis at the end of 2021. (Delta 9 Analytical ensures hemp and hemp-derived products don’t exceed the potency threshold for THC.)

“You have a choice in banking: you all run after the same business and compete, or find niche markets,” said Melissa Marsal, chief operating officer of West Town. “We did our homework and the market showed that this was an underserved market where we could build up our deposit base.”

Some of the complications for West Town include understanding the nuances in state laws, such as whether marijuana is permitted for medical or recreational use; ensuring the business is not selling to minors; and being unable to process payments using traditional rails for businesses related to cannabis with high levels of THC. The bank can process payments for hemp businesses in a traditional manner.

The $453 million-asset West Town started piloting software from RiskScout, provider of an onboarding and due diligence platform that focuses on high-risk markets, in early 2020 after Marsal met founder Justin Fischer at a conference. When a cannabis-related business wants to become a West Town customer, the applicant answers questions in a web portal provided by RiskScout about the type of business and location and uploads documentation. This primes the bank for an introductory call if it feels the applicant is a good fit.

RiskScout then conducts its own version of a higher-risk Know Your Business program that scours negative news, watch lists and more. Once the business is onboarded, RiskScout takes care of ongoing monitoring and enhanced due diligence.

“Regulators want to know that you have a partner like RiskScout,” said Marsal.

Lead Bank in Missouri, which has $745.3 million of assets, has been banking the cannabis industry since the beginning of 2019. It turned to Dama Financial, a company that helps banks handle cannabis businesses with banking and merchant services, cash management and more, for help sourcing customers, initial due diligence and ongoing monitoring. Lead Bank then layers on artificial intelligence-based transaction monitoring software from Verafin on the back end, a way of “conducting due diligence on the due diligence that has already been conducted,” said Schneider.

“There is a very high resource requirement to bank the cannabis industry and we would not be able to do it to this level without partnering with a fintech like Dama,” said Schneider.

Valley National Bancorp in New York City is piloting a digital payment app called ValleyPay that will function like a reloadable gift card. Cannabis consumers will be able to fund the card from their accounts and use a QR code to pay merchants. The bank is working with Green Check Verified, a technology and advisory company for cannabis banking, and T-Recs, an account reconciliation tool from financial software provider Trintech, to automatically reconcile, verify and monitor transactions at the point of sale and on the back end.

“The tide is moving in a very clear direction,” said Rick Kraemer, chief financial services officer at the $43.4 billion-asset Valley. “We saw an opportunity to provide a better service and we wanted to be part of the solution, taking cash out of the system.”

The availability of such technology is also relevant for banks that are interested in banking cannabis companies, but not quite there.

“A lot of banks are sitting on sidelines and waiting for legislation on the federal level,” said Hunter Robinson, partner in the financial services and cannabis practice groups at Bradley Arant Boult Cummings. “For banks that know they will do this when they have legislative cover, the time to start preparing is now.”